EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres

Natália Hogetop Freire, Alice Laschuk Herlinger, Julia Vanini iD, Matheus Dalmolin, Marcelo A C Fernandes iD, Carolina Nör, Vijay Ramaswamy iD, Caroline Brunetto de Farias, André Tesainer Brunetto iD, Algemir Lunardi Brunetto iD, Lauro José Gregianin, Mariane da Cunha Jaeger und 2 weitere

Cells · 2025

DOI: 10.3390/cells14020072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Natália Hogetop Freire und 13 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Institute (ICI), Porto Alegre 90620-110, RS, Brazil. Hauptthemen laut MEDLINE: Valproic Acid, Medulloblastoma, Cell Differentiation, Neoplastic Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Canada, Brain Tumour Charity, National Council for Scientific and Technological Development (CNPq, MCTI, Brazil).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Changes in epigenetic processes such as histone acetylation are proposed as key events influencing cancer cell function and the initiation and progression of pediatric brain tumors. Valproic acid (VPA) is an antiepileptic drug that acts partially by inhibiting histone deacetylases (HDACs) and could be repurposed as an epigenetic anticancer therapy. Here, we show that VPA reduced medulloblastoma (MB) cell viability and led to cell cycle arrest. These effects were accompanied by enhanced H3K9 histone acetylation (H3K9ac) and decreased expression of the MYC oncogene. VPA impaired the expansion of MB neurospheres enriched in stemness markers and reduced MYC while increasing TP53 expression in these neurospheres. In addition, VPA induced morphological changes consistent with neuronal differentiation and the increased expression of differentiation marker genes TUBB3 and ENO2. The expression of stemness genes SOX2, NES, and PRTG was differentially affected by VPA in MB cells with different TP53 status. VPA increased H3K9 occupancy of the promoter region of TP53. Among the genes regulated by VPA, the stemness regulators MYC and NES showed an association with patient survival in specific MB subgroups. Our results indicate that VPA may exert antitumor effects in MB by influencing histone acetylation, which may result in the modulation of stemness, neuronal differentiation, and the expression of genes associated with patient prognosis in specific molecular subgroups. Importantly, the actions of VPA in MB cells and neurospheres include a reduction in the expression of MYC and an increase in TP53.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidMedulloblastomaCell DifferentiationNeoplastic Stem CellsCerebellar NeoplasmsHumansCell Line, TumorAcetylationHistonesGene Expression Regulation, NeoplasticTumor Suppressor Protein p53Cell SurvivalCell Proliferation

Stichwörter der Autor:innen

MYCTP53differentiationmedulloblastomastemnessvalproic acid

Substanzen

Valproic AcidHistonesTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Children's Cancer Institute (ICI), Porto Alegre 90620-110, RS, Brazil.
  • Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.
  • National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, RS, Brazil.
  • InovAI Lab, nPITI/IMD, Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.
  • Bioinformatics Multidisciplinary Environment (BioME), Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.
  • Department of Computer Engineering and Automation, Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.

ORCID-Profile: Julia Vanini, Marcelo A C Fernandes, Vijay Ramaswamy, André Tesainer Brunetto, Algemir Lunardi Brunetto, Rafael Roesler

Förderung

  • Brain Canada
  • Brain Tumour Charity
  • National Council for Scientific and Technological Development (CNPq, MCTI, Brazil)
  • National Institutes of Health (NIH)
  • Canada Research Chair in Pediatric Neuro-Oncology
  • Cancer Prevention and Research Institute of Texas (CPRIT)
  • William Donald Nash Brain Tumour Research Fellowship
  • Children's Cancer Institute (ICI)

Zitieren

APA

Freire, N. H., Herlinger, A. L., Vanini, J., Dalmolin, M., Fernandes, M. A. C., Nör, C., Ramaswamy, V., de Farias, C. B., Brunetto, A. T., Brunetto, A. L., Gregianin, L. J., Jaeger, M. D. C., Taylor, M. D., & Roesler, R. (2025). Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres. Cells. https://doi.org/10.3390/cells14020072

Vancouver

Freire NH, Herlinger AL, Vanini J, Dalmolin M, Fernandes MAC, Nör C, et al. Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres. Cells. 2025. doi:10.3390/cells14020072

BibTeX
@article{Freire2025,
  author = {Freire, Natália Hogetop and Herlinger, Alice Laschuk and Vanini, Julia and Dalmolin, Matheus and Fernandes, Marcelo A C and Nör, Carolina and Ramaswamy, Vijay and de Farias, Caroline Brunetto and Brunetto, André Tesainer and Brunetto, Algemir Lunardi and Gregianin, Lauro José and Jaeger, Mariane da Cunha and Taylor, Michael D and Roesler, Rafael},
  title = {Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14020072}
}
Kostenlos starten →